Results 91 to 100 of about 1,465,354 (287)

Evaluation of Antiphospholipid Antibodies and Activated Partial Thromboplastin Time in Women with Adverse Outcome of Pregnancy [PDF]

Iranian Journal of Medical Sciences, 2010
Adverse outcome of pregnancy is a potentially dangerouscomplication of conception and affects 15-20% of pregnancies.According to recent studies increased level of bloodantiphospholipids antibodies, if accompanied by predisposingfactors, can be an adverse
Sariyeh Golmahammad lou, Nader Pashapour, Mahnaz khalili, Farzaneh Broomand, Fatemeh Bahadori   +4 more
doaj  

Antiphospholipid Syndrome Antibodies — Snippets from the Laboratory

Proceedings of Singapore Healthcare, 2013
Antiphospholipid (aPL) antibodies refer to antibodies associated with the clinical syndrome of vascular thrombosis and/or pregnancy morbidity, termed as aPL syndrome (APS).
Justin Hung Tiong Tan MBBS, MRCPCH (UK), Cecilia Ngan MBBS, MSc, FRCPA, FAMS, Thaschawee Arkachaisri MD, FACR   +2 more
doaj   +1 more source

Ocular perfusion pressure and anticardiolipin antibodies in glaucomatous Egyptian patients

Delta Journal of Ophthalmology, 2016
Aim The aim of the present study was to investigate the association of antiphospholipid antibodies and ocular perfusion pressure (OPP) with primary open-angle glaucoma (POAG) in an Egyptian population.
Maha Shahin, Hossam T Al-Sharkawy, Amany M El-Diasty   +2 more
doaj   +1 more source

Kidney disease in primary anti-phospholipid antibody syndrome [PDF]

, 2017
APS is an autoimmune disease defined by the presence of arterial or venous thrombotic events and/or pregnancy morbidity in patients who test positive for aPL. APS can be isolated (primary APS) or associated with other autoimmune diseases. The kidney is a
Gracia-Tello, B, Isenberg, D
core  

Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus. [PDF]

, 1992
The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphospholipid antibodies in systemic lupus erythematosus (SLE), 95 patients with SLE were studied.
Cervera i Segura, Ricard, 1960-, Haga, Hans J., Hughes, Graham R. V. (Graham Robert Vivian), Khamashta, Munther A., Tripathi, Poonam, Vianna, Joao L.   +5 more
core   +1 more source

A 17-Year-Old Female with Systemic Lupus Presents with Complex Movement Disorder: Possible Relationship with Antiribosomal P Antibodies

Case Reports in Neurological Medicine, 2013
Complex movement disorder is a relatively rare presentation of neurolupus. Antiphospholipid antibodies are associated with movement disorders likely via aberrant neuronal stimulation.
Muhammed Emin Özcan, Meriç Adil Altınöz, Hasan Hüseyin Karadeli, Talip Asil, Abdulkadir Koçer   +4 more
doaj   +1 more source

Anticardiolipin Antibodies in Patients with Cancer: A Case-Control Study. [PDF]

Cancers (Basel), 2023
Nipu MAI, Kundu S, Alam SS, Dina AN, Hasan MA, Khan M, Khalil MI, Hossan T, Islam MA.   +8 more
europepmc   +1 more source

Lupus nephritis. Part II. A clinicopathological correlation and study of outcome [PDF]

, 1991
CITATION: Halland, A.-M. et al. 1991. Lupus nephritis. Part II. A clinicopathological correlation and study of outcome. South African Medical Journal, 79:260-264.The original publication is available at http://www.samj.org.zaA 5-year retrospective study ...
Halland, A.-M., Bates, W. D., Tribe, R. D., Cooper, R., Chalton, D., Klemp, P.   +5 more
core  

Gestation in patients with high levels of anticardiolipin antibodies, a history of deep venous thrombosis and miscarriages

Archives of Medical Science, 2006
The aim is to stress the importance of prophylaxis against deep venous thrombosis in gravidas with high levels of anticardiolipin antibodies with or without a history of repetitive miscarriages.
José Maria Pereira de Godoy, Ligia Cosentino Junqueira Franco Spegiorin, Juliana Dallaqua, Cecília Freire de Carvalho de Carvalho, Iara Lima Costa   +4 more
doaj  

Prevalence and coagulation correlation of anticardiolipin antibodies in patients with COVID-19. [PDF]

Medicine (Baltimore), 2022
Zeng H, Cai M, Xue H, Xie W, Long X.
europepmc   +1 more source